Table 3.
Univariate and multivariate analysis of serum miR-9 expression in OSCC disease free survival.
| Parameters | Overall survival | |||
|---|---|---|---|---|
| Univariate OR (95%CI) | P | Multivariate OR (95%CI) | P | |
| Gender (Male vs. Female) | 1.484 (0.581–2.308) | 0.345 | ||
| Age (>60 vs. ≤60) | 1.208 (0.348–1.560) | 0.620 | ||
| Smoking status (Smoker vs. Non-smoker) | 1.639 (0.394–2.836) | 0.196 | ||
| Tumor site (Tongue vs. Non-tongue) | 0.940 (0.621–1.388) | 0.765 | ||
| T stage (T3–T4 vs. T1–T2) | 2.631 (1.378–4.293) | 0.043 | 2.738 (0.985–3.952) | 0.058 |
| Lymph node metastasis (Yes vs. No) | 5.829 (2.571–10.686) | 0.005 | 6.521 (2.524–11.630) | 0.006 |
| TNM stage (III–IV vs. I–II) | 3.487 (1.492–5.363) | 0.031 | 3.295 (1.407–4.259) | 0.040 |
| Grade (Poor vs. Well/moderate) | 2.282 (0.954–3.473) | 0.062 | ||
| Serum miR-9 expression (Low vs. High) | 4.420 (1.813–7.362) | 0.011 | 4.592 (1.924–8.271) | 0.018 |